Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat Sodium in OPCABG
NCT07118930Phase 2Recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Aug 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sivelestat in Myocardial injury, sponsored by Affiliated Hospital of Nantong University. Started Aug 2025; status: recruiting.
02
Drugs
sivelestat
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT07118930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07118930.